MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    Beyond α-Synuclein SAA: A Multimodal Minimally Invasive Platform for Biologically Informed Diagnosis of Parkinsonian Syndromes

    I. Martinez-Valbuena, M. Abarghouei, D. Olszewska, S. Weber, S. Schnell, M. Sousa, D. Di Luca, N. Reyes, SM. Fereshtehnejad, J. Ta, C. Anastassiadis, J. Li, J. Sasitharan, N. Visanji, S. Fox, B. Mollenhauer, C. Tartaglia, G. Kovacs, A. Lang (Toronto, Canada)

    Objective: To evaluate whether integrating dermal α-synuclein and 4R-tau seed amplification assays (SAAs) with serum neurofilament light chain (NfL) improves diagnostic precision in neurodegenerative parkinsonian…
  • 2026 International Congress

    Integrating Transcriptomics and Morphological Profiling to Characterize GBA-Associated Parkinson’s Disease in Midbrain Organoids

    F. Nasta, E. Glaab, JC. Schwamborn (Esch-sur Alzette, Luxembourg)

    Objective: This study characterizes converging biological trends in GBA-associated Parkinson’s Disease by integrating transcriptomic profiling with exploratory image-based analysis of donor-matched midbrain organoids. Background: High-content…
  • 2026 International Congress

    Does Unilateral MR-Guided Focused Ultrasound Subthalamotomy Provide Bilateral Motor Benefit in Parkinson Disease

    E. Navarro-Mocholí, M. Campins-Romeu, R. Conde-Sardón, I. Sastre-Bataller, M. Losada-López, C. Morata-Martínez, MJ. Ibáñez-Julià, MN. Afkir-Ortega, AM. Lozano, A. Gutiérrez-Martín, I. Martínez-Torres (Valencia, Spain)

    Objective: To evaluate the effect of unilateral STN-MRgFUS on ipsilateral motor symptoms at 6 and 12 months post-procedure. Background: In patients with Parkinson’s disease (PD)…
  • 2026 International Congress

    Cannabis-based Oil for Pain and Other Non-motor Symptoms in Parkinson’s Disease: a Randomized Controlled Trial

    A. Alves, J. Parmera, G. Kubota, P. Martins, M. Deltreggia, A. Falcone, A. Santana, M. Falcão, M. Dias, L. Moreira, P. Filho, E. Figueiredo, E. Barbosa, R. Cury, D. Andrade (São Paulo, Brazil)

    Objective: To assess the safety, tolerance, and effectiveness of an oil extract of Cannabis sativa L. on pain and other non-motor symptoms (NMS) in people…
  • 2026 International Congress

    Epidemiology of Parkinson’s Disease and Parkinsonism in Kazakhstan from 2015 to 2024 based on National Health Data

    ZH. Myrzayev, G. Saidakhmetova, B. Abdenov, M. Zholdybayeva, A. Muratbaikyzy, G. Mussagaliyeva, CH. Shashkin, R. Kaiyrzhanov (Almaty, Kazakhstan)

    Objective: To evaluate the prevalence and dynamics of Parkinson’s disease and parkinsonian syndromes in the population of Kazakhstan from 2015 to 2024 using data from…
  • 2026 International Congress

    Progressive Lifelong Chorea with Spastic Paraparese and Cerebellar Ataxia Associated with Two Heterozygous Variants in the SYNE1 Gene: A Case Report

    I. Sarac, H. Sarac, F. Borovecki, N. Henigsberg (Zagreb, Croatia)

    Objective: To report a case harboring two different heterozygousSYNE1 variants whose combined effect is suspected tounderlie a complex neurogenetic phenotype Background: SYNE1 encodes nesprin-1, one…
  • 2026 International Congress

    The Impact of Demographic Factors on Skull Density Ratios in a Hawaii Cohort

    K. Thai, F. Gao, M. Morita, R. Shuman, M. Faouzi, E. Krening, M. Bruno (Honolulu, USA)

    Objective: To understand the impact of demographic factors on skull density ratio (SDR) in Hawai‘i patients. Background: SDR is a validated indicator of the ability…
  • 2026 International Congress

    Robot-Assisted Transplantation of Hypoimmune iPSC Derived Dopaminergic Progenitor Cells for Idiopathic Parkinson’s Disease

    J. Shi, J. Yu, C. Han, A. Chen, L. Jiao, R. Qian (Hefei, China)

    Objective: This study aimed to evaluate the 12-month safety and preliminary efficacy of NCR201 transplantation in idiopathic PD patients, providing a proof-of-concept for universal cell…
  • 2026 International Congress

    Anti-IgLON5 Encephalitis Presenting as Chronic Progressive Asymmetrical Ataxia and Chorea

    P. Kosiyakul, J. Jitprapaikulsan, Y. Pitakpatapee (Bangkok, Thailand)

    Objective: To report a case of gait instability and progressive asymmetrical chorea clinically confirmed as anti-IgLON5 encephalitis. Background: Anti-IgLON5 encephalitis is a rare autoimmune neurological…
  • 2026 International Congress

    Pharmacogenomic Analysis of KM-819-Related Hepatotoxicity in Patients with Multiple System Atrophy

    J. Han, R. Andrade, ES. Björnsson, JH. Lewis, MI. Lucena, S. Go, S. Stankeviciute, G. Aithal, G. Kim, C. Lee, C. Barlow, E. Kim (Bundang-gu, Republic of Korea)

    Objective: This study aimed to identify genetic risk factors linked to a drug candidate for MSA (KM-819)-associated drug-induced liver injury (DILI) in patients with multiple…
  • « Previous Page
  • 1
  • …
  • 29
  • 30
  • 31
  • 32
  • 33
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley